We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Cancer Detected by Dynamic Morphology Tracking on Aptamer-Grafted Surfaces

By LabMedica International staff writers
Posted on 22 Dec 2015
Cell motility is a phenomenon where cells move by protruding and contracting sections of the membrane that is a complex process performed through sophisticated balancing act between internal cytoskeleton structure and the cell membrane proteins.

Cancer cells are known to be abnormally flexible compared to healthy cells, primarily due to their inherent weak structures and the forces between the cytoskeleton and the cell surface proteins which differ between cancerous and healthy cells. More...
The surface receptors are found in large numbers on the surface of cancer cells.

Scientists at the University of Texas (Arlington, TX, USA) and their colleagues have developed a novel cancer cell detection method based on real time cell behavior tracking on engineered surfaces. A synthetic ribonucleic acid (RNA) molecule is coated on chip surface to identify cancer cells. The one-step tumor cell detection approach is based on the dynamic morphological behavior tracking of cancer cells on a ligand modified surface.

The human glioblastoma (hGBM) cells showed distinctly enhanced cell movements and activity on the RNA functionalized chips. Every cell on the surface was tracked in real time for several minutes immediately after seeding until these were finally attached. Cancer cells were found to be very active in the aptamer microenvironment, changing their shapes rapidly from spherical to semi-elliptical, with much flatter spread and extending pseudopods at regular intervals.

When incubated on a functionalized surface, the balancing forces between cell surface molecules and the surface-bound aptamers together with the flexibility of the membranes caused cells to show these distinct dynamic activities and variations in their morphologies. On the other hand, healthy cells remained distinguishingly inactive on the surface over the same period. The quantitative image analysis of cell morphologies provided feature vectors that were statistically distinct between normal and cancer cells.

Samir Iqbal, PhD. the principal investigator of the study said, “The initial results hold great potential for applications like cancer screening. A multiple chip based device targeting several proteins can lead to a generic cancer diagnostic platform. The advantage of the technology compared to others is that it is suitable for a quick diagnosis. Once matured, the method has potential to serve as an additional modality to identify tumor cells based on their physical behavior from blood samples or biopsy specimen directly drawn from patients.” The study was published on November 16, 2015, in the journal TECHNOLOGY.

Related Links:

University of Texas



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Pipet Controller
Stripettor Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.